Promoters exhibiting endothelial cell specificity and methods of using same

Details for Australian Patent Application No. 2003222427 (hide)

International Classifications

Event Publications

7 August 2003 Complete Application Filed

Priority application(s): 10/135,447 01.05.02 US

8 January 2004 Application Open to Public Inspection

Published as AU-B-2003222427

6 January 2005 Amendment Made

The nature of the amendment is as shown in the statement(s) filed 17 Nov 2004 2003223127 LG Electronics Inc. The nature of the amendment is as shown in the statement(s) filed 02 Dec 2004

31 January 2008 Amendment Made

The nature of the amendment is: Add co-inventor name to read Brietbart, Eyal

6 March 2008 Corrigenda

Amendments - Amendments Made Under the name Vascular Biogenics Ltd., Application No. 2003222427, under INID (72), correct the co-inventor name to read Breitbart, Eyal

13 November 2008 Amendment Made

The nature of the amendment is: Amend the name of the inventor to read Harats, Dror; Bloom, Nira and Breitbart, Eyal

11 February 2010 Amendment Made

The nature of the amendment is: Amend the priority details under INID (62) to add divisional detail 2002224002

25 March 2010 Application Accepted

Published as AU-B-2003222427

29 April 2010 Corrigenda

Applications Accepted - Name Index Under the name Vascular Biogenics Ltd., Application No. 2003222427, under INID (22) correct the filing date to read 30 April 2003

23 September 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.